RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

It's an interesting question. My thought is, in this litigitous age: If you have CX1942 being developed for RD, I question whether some "enterprising dr or med researcher' is going to mess around with CX1739 for an off-label use where the stakes are so high. Who wants to get sued for that? Maybe the CX1942 licensor would want Cortex to guarantee they won't license CX1739 to someone else for RD, but I don't think off-label use for RD is an issue--not in hospital or surgical center settings. Hospital attorneys would go berserk....

NeuroInvestment